Express Pharma

WHO grants prequalification of Roche’s Actemra/RoActemra for patients with severe COVID

Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in the global treatment guidelines

0 245